Intersect ENT Competitors and Similar CompaniesClear all

Intersect ENT's competitors and similar companies include Stryker and OptiNose.
Intersect ENT
Intersect ENT
Intersect ENT (also known as Medtronic Ear, Nose & Throat) is an ear, nose, and throat medical technology company.
Stryker
Stryker
Stryker is a company that develops medical, surgical, neurotechnology, orthopedics, and spine products.
OptiNose
OptiNose
OptiNose develops nasal drug delivery technologies and combination drug-device therapies.
Founding Date
Founding Date
2003
Founding Date
1941
Founding Date
2000
Type
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Menlo Park, US HQ
Locations
Portage, US HQ
Munro, AR
Sydney, AU
Vienna, AT
Machelen, BE
São Paulo, BR
London, CA
see more
Locations
Morrisville, US HQ
Oslo, NO
Swindon, GB
Employees
Employees
4337% increase
Employees
53,0002% increase
Employees
2048% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
135 b
Valuation ($)
118.1 m

Financial

Revenue (est.)
Revenue (est.)
$106.7m (FY, 2021)
Revenue (est.)
$25.1b (FY, 2025)
Revenue (est.)
$78.2m (FY, 2024)
Cost of goods
Cost of goods
$30m (FY, 2021)
Cost of goods
$9.1b (FY, 2025)
Cost of goods
$7.2m (FY, 2024)
Gross profit
Gross profit
$76.7m (FY, 2021)
Gross profit
$16.1b (FY, 2025)
Gross profit
$71m (FY, 2024)
Net income
Net income
($159.6m) (FY, 2021)
Net income
$3.2b (FY, 2025)
Net income
($21.5m) (FY, 2024)

Operating

Patents (US)
Patents (US)
30 (FY, 2016)
Patents (US)
N/A
Patents (US)
43 (Jun, 2017)
Trademarks (US)
Trademarks (US)
4 (FY, 2016)
Trademarks (US)
N/A
Trademarks (US)
3 (Jun, 2017)

Funding

Total funding raised
Total funding raised
$ 102.9m
Total funding raised
N/A
Total funding raised
$ 120.5m
For sources of this data, please see the company profile

View Company Profiles

Stryker
HQ
Portage, US
Employees
53,000↑ 2% increase

Stryker is a company that develops medical, surgical, neurotechnology, orthopedics, and spine products.

View company
OptiNose
HQ
Morrisville, US
Employees
204↓ 8% decrease

OptiNose develops nasal drug delivery technologies and combination drug-device therapies.

View company